Quantcast
Last updated on April 17, 2014 at 1:21 EDT

Latest Neurobiology Stories

2012-11-29 08:28:13

SUNNYVALE, Calif., Nov. 29, 2012 /PRNewswire/ -- Amarantus Bioscience, Inc. (OTCQB: AMBS), a biotechnology company developing new treatments and diagnostics for Parkinson's disease and Traumatic Brain Injury centered on its proprietary anti-apoptosis therapeutic protein MANF, today announced that an independent peer-reviewed research paper entitled Upregulation of mesencephalic astrocyte-derived neurotrophic factor in glial cells is associated with ischemia-induced glial activation...

2012-11-23 10:40:03

IRCM researchers discover a nerve cell´s internal clock A team of IRCM researchers, led by Dr. Frédéric Charron, recently uncovered a nerve cell´s internal clock, used during embryonic development. The discovery was made in collaboration with Dr. Alyson Fournier´s laboratory at the Montreal Neurological Institute. Published today in the prestigious scientific journal Neuron, this breakthrough could lead to the development of new tools to repair and...

2012-11-20 11:38:58

Johns Hopkins team first identified biochemical clue to therapy in brain scans of people with MS Johns Hopkins researchers report the successful use of a form of MRI to identify what appears to be a key biochemical marker for cognitive impairment in the brains of people with multiple sclerosis (MS). In follow-up experiments on mice with a rodent form of MS, researchers were able to use an experimental compound to manipulate that same marker and dramatically improve learning and memory....

2012-10-17 07:27:57

ROCKVILLE, Md., Oct. 17, 2012 /PRNewswire/ -- Neuralstem, Inc. (NYSE MKT: CUR) announced that it has begun dosing the second cohort of patients in its ongoing Phase Ib to test the safety of NSI-189 in the treatment of major depressive disorder (MDD). NSI-189, the lead compound in Neuralstem's neurogenic small molecule platform, is a proprietary new chemical entity that stimulates new neuron growth in the hippocampus, a region of the brain believed to be implicated in MDD, as well as other...

Silent Watchmen Attack To Defend The Nervous System
2012-10-16 17:20:26

In many pathologies of the nervous system, there is a common event - cells called microglia are activated from surveillant watchmen into fighters. Microglia are the immune cells of the nervous system, ingesting and destroying pathogens and damaged nerve cells. Until now little was known about the molecular mechanisms of microglia activation despite this being a critical process in the body. Now new research from the Montreal Neurological Institute and Hospital — The Neuro - at McGill...

2012-10-10 07:28:52

ROCKVILLE, Md., Oct. 10, 2012 /PRNewswire/ -- Neuralstem, Inc. (NYSE MKT: CUR) announced that it will present preclinical data in five poster presentations at Neuroscience 2012, the 42(nd) Annual Meeting for the Society for Neuroscience., October 13-17, in New Orleans (http://www.sfn.org/AM2012/). These posters will cover new data pertaining to Neuralstem's NSI-566 spinal cord stem cell line for cell therapy, and its patented, neurogenic small molecule compounds: NSI-144, NSI-150, NSI-158 and...

2012-09-27 00:00:21

An Evolutionary Biologist at The University of Manchester, working with scientists in the United States, has found compelling evidence that parts of the brain can evolve independently from each other. It's hoped the findings will significantly advance our understanding of the brain. The unique 15 year study with researchers at the University of Tennessee and Harvard Medical School also identified several genetic loci that control the size of different brain parts. The aim of the...

2012-09-13 06:30:59

ROCKVILLE, Md., Sept. 13, 2012 /PRNewswire/ -- Neuralstem, Inc. (NYSE MKT: CUR) announced that its neural stem cells were part of a study, "Long-Distance Growth and Connectivity of Neural Stem Cells After Severe Spinal Cord Injury: Cell-Intrinsic Mechanisms Overcome Spinal Inhibition," published online today in a leading scientific journal CELL (http://www.cell.com/current). In the study, rats with surgically transected spinal cords, which rendered them permanently and completely paraplegic,...

2012-09-11 02:29:31

ROCKVILLE, Md., Sept. 11, 2012 /PRNewswire/ -- Neuralstem, Inc. (NYSE MKT: CUR) announced that Karl Johe, PhD, will give an update on the NSI-189 ongoing clinical trial in major depressive disorder (MDD) at the 6(th) Neurodegenerative Conditions Research and Development conference, September 13-14, in San Francisco, CA (http://www.gtcbio.com/index.php?option=com_conference&file=speaker&cn=5th%20Neurodegenerative&cid=37). NSI-189 is the lead compound in Neuralstem's neurogenic...

2012-09-08 23:00:02

The abstract submission titled “Clinical Results from a Multicenter Registry Study on the Use of Processed Nerve Allograft for Sensory, Mixed and Motor Nerve Repairs” was selected for an Outstanding award and poster display at AATB 2012 Annual Meeting. Alachua, FL (PRWEB) September 07, 2012 AxoGen Inc., Inc. (OTCBB: AXGN), a leader in the science and commercialization of surgical solutions for peripheral nerve repair, announced today that its submission titled “Clinical...


Latest Neurobiology Reference Libraries

Brain
2013-03-05 13:54:00

Formation and Orientation The development of the brain is broken down into stages. The basic evolution begins in the third week of the embryonic process where the neural plate is formed. By week four, the neural plate has developed into the neural tube. The anterior part of the tube, the telencephalon, grows rapidly as it prepares to later give way to the brain. As time goes on, cells begin to classify themselves as either neurons or glial cells, thus determining their functions. Glial...

More Articles (1 articles) »